WuXi Chemistry

Thank you for joining WuXi STA and WuXi TIDES at #CPHIMilan 2024! We had an incredible time connecting with so many longtime friends and meeting with industry experts. Your enthusiasm and engagement made this year’s event truly unforgettable. Over the past few days, we discussed how our comprehensive CRDMO services can support projects from early development through commercialization. Whether you’re focused on small molecules, oligonucleotides, peptides, or complex conjugates, our global team is committed to helping streamline your drug development journey. Missed us at the event? Reach out to learn more about how we can support your next project https://lnkd.in/esJjxutd

Visit WuXi STA at Booth 1730 during the AAPS 2024 in Salt Lake City from Oct. 20-23! Explore how our integrated CMC services can streamline your drug development journey with WuXi Speed. From drug substance to drug product development, whether oral solids or sterile injectables, we specialize in all synthetic molecules, including small molecules, oligonucleotides, peptides, and their complex conjugates. Plus, don’t miss our Happy Hour on Oct. 22, from 3:00–4:00 PM at our booth! Come for a drink, network with formulation experts, and discover how we can support your projects! Planning to attend? Pre-schedule a meeting with us: https://lnkd.in/e_FcU25b

Join WuXi STA at Booth 17 at Formulation & Delivery 2024, October 16-17, in San Diego. Our Drug Product Platform provides end-to-end formulation development and manufacturing solutions for both oral solids and parenterals. With a suite of advanced bioavailability enhancement technologies, we tackle complex solubility and delivery challenges. Backed by a dual supply chain across Asia and Europe, we ensure reliable, flexible solutions tailored to your project needs. Schedule a meeting with us to learn more: STA_info@wuxiapptec.com #FormulationAndDelivery #DrugDevelopment #Bioavailability #CMC

#CPHI Worldwide 2024 in Milan is officially underway! Our WuXi STA and WuXi TIDES teams are on-site at Booth 2B18 in the API Hall, ready to connect with you. From small molecule drug substances to advanced oligonucleotide and peptide solutions, we’re here to discuss how our integrated CRDMO services can support your project’s success—whether you’re in early development or nearing commercialization. Take this opportunity to meet our global team and discover how we can accelerate your pharmaceutical development journey with WuXi Speed. #CPHI2024 #CRDMO #CMC #WuXiSTA #WuXiTIDES

The energy is high at the Oligonucleotide Therapeutics Society 2024 in Montreal! Our WuXi TIDES team is excited to connect with you at Booth 4-1 and discuss how our comprehensive oligonucleotide CRDMO platform can support your projects from discovery through commercial manufacturing. Whether you’re advancing ASOs, siRNAs, PMOs, or complex oligonucleotide conjugates, we provide the expertise and tailored solutions to support your projects, at any stage and scale. Looking for high-quality amidite building blocks? Explore our TIDES Catalog (https://lnkd.in/exwmTMhx) and accelerate your oligonucleotide synthesis with WuXi Speed. #OTS2024 #oligonucleotides #siRNA #WuXiTIDES #CRDMO

Join WuXi STA at the BioNTX 2024 iC³ Life Science & Healthcare Innovation Summit in Arlington, TX! Discover how our integrated CMC services can accelerate your small molecule projects from preclinical stages to commercial manufacturing with WuXi Speed and flexibility. From API and drug product development to analytical studies and regulatory support, our experts streamline each phase of your project for a smoother path to market. Let’s connect on-site and explore how we can support your next innovation. #WuXiSTA #SmallMolecules #CRDMO #Innovation #DrugSubstance #DrugProduct

We're here at the 14th Annual Injectables Summit in Boston! WuXi STA's Drug Product Platform provides integrated parenteral drug development and manufacturing for all synthetic modalities, including small molecules, oligonucleotides, peptides, and their conjugates, with various dosage forms and filling formats. With optimized processes, we minimize API usage in formulation and testing, and ensure a GMP line loss of less than 20 mL for high-cost APIs. Stop by to meet our team and discover how we can support your parenteral development needs. #Injectables #DrugDevelopment #CMC #WuXiSTA

Team WuXi TIDES is thrilled to be acknowledged in a recent publication by Avidity Biosciences in the Journal of Medicinal Chemistry, which explores the optimization of antibody–oligonucleotide conjugates for enhanced siRNA delivery. A special shout-out to Baorui Lin and Zhanlei Wei from the Oligonucleotide Discovery Team at WuXi TIDES for their work on the synthesis and scale-up of vp-UNA-3′-phosphoramidite. Their work exemplifies the quality and efficiency WuXi TIDES strives for in every project, advancing the development of innovative oligonucleotide therapeutics. 💡 Discover more about their findings: https://lnkd.in/ejHwuK5w #WuXiTIDES #Oligonucleotides #CRDMO #WuXiSpeed

The countdown is on—just one week until CPHI Milan! Don’t miss your chance to connect with WuXi STA and WuXi TIDES experts at Booth 2B18 in the API Hall. Our comprehensive CRDMO services span small molecule drug substances, drug products, and advanced oligonucleotide and peptide solutions. Whether you’re in the early stages of development or nearing commercialization, our global team is ready to partner with you to support your project’s success. Let's talk about how our integrated services can streamline your pharmaceutical development process: https://lnkd.in/e_FcU25b #CPHI2024 #CRDMO #SmallMolecule #CMC #Oligonucleotides #Peptides